GEOFFREY CARLSON: Open Payments
NPI 1417990904 · CLINTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $155 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $183 |
| ABBVIE INC. | 4 | $77 |
| Edwards Lifesciences Corporation | 2 | $65 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| Exact Sciences Corporation | 3 | $42 |
| PFIZER INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
| Organon LLC | 1 | $15 |
Products named: Ozempic, GVOKE HYPOPEN, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), NURTEC ODT, UBRELVY, MOUNJARO, Rybelsus, The Cologuard Plus Collection Kit.
Industry payments across SC — which companies pay providers there.
